Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
Go back to Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer| AGENUS (NASDAQ: AGEN) | Delayed: 8.09 +0.60 (8.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.49 | 52 Week High | $7.49 | |||
| Open | $7.58 | 52 Week Low | $2.61 | |||
| Day High | $8.35 | P/E | N/A | |||
| Day Low | $7.58 | EPS | $-1.10 | |||
| Volume | 1,517,505 | |||||
| (NASDAQ: GANX) | Delayed: 2.01 +0.03 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.98 | 52 Week High | $ | |||
| Open | $2.00 | 52 Week Low | $ | |||
| Day High | $2.05 | P/E | N/A | |||
| Day Low | $1.98 | EPS | $ | |||
| Volume | 277,477 | |||||

